179 related articles for article (PubMed ID: 10852279)
1. A Canadian survey on the management of corticosteroid induced osteoporosis by rheumatologists.
Soucy E; Bellamy N; Adachi JD; Pope JE; Flynn J; Sutton E; Campbell J
J Rheumatol; 2000 Jun; 27(6):1506-12. PubMed ID: 10852279
[TBL] [Abstract][Full Text] [Related]
2. Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment.
Solomon DH; Levin E; Helfgott SM
J Rheumatol; 2000 Jun; 27(6):1496-500. PubMed ID: 10852277
[TBL] [Abstract][Full Text] [Related]
3. 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.
Sebaldt RJ; Ioannidis G; Adachi JD; Bensen WG; Bianchi F; Cividino A; Gordon M; Kaminska E; Scocchia T; Petrie A; Stephenson GF; Goldsmith CH
J Rheumatol; 1999 Jul; 26(7):1545-9. PubMed ID: 10405943
[TBL] [Abstract][Full Text] [Related]
4. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
Smith MD; Cheah SP; Taylor K; Ahern MJ
J Rheumatol; 2001 Mar; 28(3):566-70. PubMed ID: 11296960
[TBL] [Abstract][Full Text] [Related]
5. A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America.
Soybilgic A; Tesher M; Wagner-Weiner L; Onel KB
Pediatr Rheumatol Online J; 2014; 12():24. PubMed ID: 25053923
[TBL] [Abstract][Full Text] [Related]
6. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.
Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah I; Chow SK; Goh EM
J Rheumatol; 2008 Dec; 35(12):2344-7. PubMed ID: 19004038
[TBL] [Abstract][Full Text] [Related]
7. Prevention of corticosteroid-induced osteoporosis: results of a patient survey.
Buckley LM; Marquez M; Feezor R; Ruffin DM; Benson LL
Arthritis Rheum; 1999 Aug; 42(8):1736-9. PubMed ID: 10446875
[TBL] [Abstract][Full Text] [Related]
8. Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty.
Buckley LM; Marquez M; Hudson JO; Downs RW; Vacek P; Small RE; Poses R
J Rheumatol; 1998 Nov; 25(11):2195-202. PubMed ID: 9818664
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.
Lane NE; Sanchez S; Modin GW; Genant HK; Pierini E; Arnaud CD
J Clin Invest; 1998 Oct; 102(8):1627-33. PubMed ID: 9788977
[TBL] [Abstract][Full Text] [Related]
10. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
Ledwich LJ; Clarke K
J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid-induced bone loss. Prevention and management.
Picado C; Luengo M
Drug Saf; 1996 Nov; 15(5):347-59. PubMed ID: 8941496
[TBL] [Abstract][Full Text] [Related]
12. [Corticosteroid-induced osteoporosis-- prevention and treatment].
Elkayam O; Paran D; Yaron M; Caspi D
Harefuah; 1999 Mar; 136(6):489-92. PubMed ID: 10914270
[No Abstract] [Full Text] [Related]
13. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
Sato S; Takada T; Katsuki Y; Kimura N; Kaneko Y; Suwa A; Hirakata M; Kuwana M
J Rheumatol; 2008 Jan; 35(1):142-6. PubMed ID: 18050368
[TBL] [Abstract][Full Text] [Related]
14. Practice variation in the diagnosis and treatment of osteoporosis: a case for more effective physician education in primary care.
Saadi H; Litaker D; Mills W; Kippes C; Richmond B; Licata A
J Womens Health Gend Based Med; 1999; 8(6):767-71. PubMed ID: 10495258
[TBL] [Abstract][Full Text] [Related]
15. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
16. Prevention and management of osteoporosis in men receiving androgen deprivation therapy: a survey of urologists and radiation oncologists.
Alibhai SM; Rahman S; Warde PR; Jewett MA; Jaffer T; Cheung AM
Urology; 2006 Jul; 68(1):126-31. PubMed ID: 16844454
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of corticosteroid-induced osteoporosis.
Iwamoto J; Takeda T; Sato Y
Yonsei Med J; 2005 Aug; 46(4):456-63. PubMed ID: 16127768
[TBL] [Abstract][Full Text] [Related]
18. Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis.
Crilly RG; Sebaldt RJ; Hodsman AB; Adachi JD; Brown JP; Goldsmith CH; Hanley DA; Olszynski WO; Ste-Marie LG; Stephenson GF
Osteoporos Int; 2000; 11(7):607-14. PubMed ID: 11069195
[TBL] [Abstract][Full Text] [Related]
19. [Post-steroidal osteoporosis].
Drozdzowska B; Pluskiewicz W
Przegl Lek; 1999; 56(2):157-60. PubMed ID: 10375951
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group.
Roux C; Oriente P; Laan R; Hughes RA; Ittner J; Goemaere S; Di Munno O; Pouillès JM; Horlait S; Cortet B
J Clin Endocrinol Metab; 1998 Apr; 83(4):1128-33. PubMed ID: 9543129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
